CATHERINE GASKILL: Open Payments
NPI 1316132418 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 10 payments from 7 companies in 2025. Trend: 2023 $793 · 2024 $679 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| AtriCure, Inc. | 2 | $192 |
| Abbott Laboratories | 1 | $110 |
| Medtronic, Inc. | 3 | $74 |
| GENZYME CORPORATION | 1 | $28 |
| PFIZER INC. | 1 | $25 |
| Edwards Lifesciences Corporation | 1 | $17 |
| Kestra Medical Technology Services, Inc. | 1 | $15 |
Products named: EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, AVEIR, LINQ II, FABRAZYME, ELIQUIS, PULSESELECT, MICRA, EVOQUE.
Industry payments across GA — which companies pay providers there.
